ArticleBMC research notes2026
Prognostic value of the hemoglobin-to-red cell distribution width ratio (HRR) in predicting mortality and rehospitalization in patients with chronic heart failure.
Article in BMC research notes, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveHeart failure (HF) represents a significant and growing global health burden. The hemoglobin-to-red cell distribution width ratio (HRR), a novel composite marker integrating oxygen-carrying capacity (hemoglobin) and red cell distribution width (RDW), has shown prognostic value in various diseases, but its role in chronic HF remains underexplored. This study aimed to evaluate the prognostic value of HRR for mortality and 12-month rehospitalization in patients with chronic HF.
resultsA total of 419 patients with chronic heart failure were included in the analysis. A lower HRR was independently associated with increased all-cause mortality. Each unit increase in HRR was associated with a 17% reduction in mortality odds (Adjusted OR: 0.83; 95% CI: 0.73-0.95; p = 0.006). This inverse relationship was significant in anemic patients but not in non-anemic patients. In contrast, HRR was not associated with rehospitalization in the overall or anemic populations, but a higher HRR was significantly associated with reduced rehospitalization odds in non-anemic patients (Adjusted OR: 0.81; 95% CI: 0.66-0.99; p < 0.05).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.